Krystal Biotech to Present at Stifel 2024 Healthcare Conference

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS) announced its participation in the Stifel 2024 Healthcare Conference on November 18, 2024, in New York. Chairman and CEO Krish S. Krishnan will participate in a fireside chat at 10:55 am ET and conduct investor meetings throughout the day. The presentation will be accessible via webcast and will be available on the company's website's Investors section.

News Market Reaction

-4.42%

1 alert

-4.42% News Effect

On the day this news was published, KRYS declined 4.42%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PITTSBURGH, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Stifel 2024 Healthcare Conference on November 18, 2024, in New York. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 10:55 am ET and host investor meetings throughout the day.

A webcast of the presentation will be available here beginning at 10:55 am ET on Monday, November 18, 2024 and will be posted on the Investors section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK® is the Company’s first commercial product, the first-ever redosable gene therapy, and the first medicine approved by the FDA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com

FAQ

When is Krystal Biotech presenting at the Stifel 2024 Healthcare Conference?

Krystal Biotech will present at the Stifel 2024 Healthcare Conference on November 18, 2024, at 10:55 am ET in New York.

Will the Krystal Biotech (KRYS) Stifel Conference presentation be available online?

Yes, the presentation will be available via webcast starting at 10:55 am ET on November 18, 2024, and will be accessible through the Investors section of Krystal Biotech's website.

Who will represent Krystal Biotech (KRYS) at the Stifel 2024 Healthcare Conference?

Krish S. Krishnan, Chairman and Chief Executive Officer of Krystal Biotech, will represent the company at the conference through a fireside chat and investor meetings.